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Abstract Class I K-mannosidases are thought to exist exclu-
sively as integral membrane proteins that play intracellulary an
essential role in the N-glycan biosynthesis. Using
[3H]Man9GlcNAc2 as a substrate, we were able to identify a
soluble K-mannosidase in human serum that trims the substrate
Man9GlcNAc2 to Man5ÿ8GlcNAc2 with Man6GlcNAc2 being
the major product. This serum mannosidase is Ca2+-dependent,
sensitive to 1-deoxymannojirimycin but insensitive to the class II
inhibitor swainsonine and, hence, belongs to class I mannosi-
dases. The enzymatic properties of the serum class I mannosidase
are similar to that of the membrane bound class I mannosidases
Golgi-mannosidase IA and IB and Man9-mannosidase.
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1. Introduction
Class I K-mannosidases speci¢cally cleave K1,2-mannose
linkages in a Ca2-dependent manner, but are inactive to-
wards arti¢cial substrates like aryl mannosides. These en-
zymes are type II integral membrane proteins that are specif-
ically retained within the endoplasmic reticulum and the Golgi
complex. Class I K-mannosidases play an essential role in N-
glycan processing during the glycoprotein biosynthesis in
mammalian cells removing up to four mannose residues
from Man9GlcNAc2 to form the oligomannosidic glycans
Man8ÿ5GlcNAc2 (for review, [1,2,3]). The oligosaccharide
Man5GlcNAc2 is the starting point for the synthesis of all
hybrid and complex N-glycans found on mammalian glyco-
proteins.
Trimming of glycoprotein N-glycans of the oligomannosidic
type, however, is not restricted to the biosynthesis but may
also occur after the exit of glycoproteins from the secretory
pathway and transport to the cell surface [4]. As has been
shown in di¡erent cell types, cell surface glycoproteins under-
go trimming of their oligomannosidic N-glycans by class I
mannosidase(s) resulting in the conversion of Man8ÿ9-
GlcNAc2 species to Man5ÿ7GlcNAc2 with Man5GlcNAc2
being the major product. Demannosylation of cell surface
glycoproteins has been shown to occur either at the cell sur-
face or during endocytosis/recycling and is regarded as a
mechanism to postbiosynthetically modify cell surface N-gly-
cans of the oligomannosidic type [4].
In an attempt to identify mannosidases involved in the cell
surface glycoprotein demannosylation, we have studied
whether K1,2-mannosidase(s), assumed to exist exclusively as
integral cellular membrane proteins, do also occur in a soluble
form in human serum. This study was prompted by the ob-
servation that a diverse range of integral membrane proteins
also exist as soluble forms in serum and other body £uids.
These soluble forms are mostly derived from the membrane
form by proteolysis [5].
In this study, we were able to identify a soluble serum K1,2-
mannosidase with enzymatic properties similar to the mem-
brane bound class I mannosidases Golgi-mannosidase IA and
IB and Man9-mannosidase. This soluble enzyme might be
involved in the postbiosynthetic demannosylation of serum
and cell surface proteins of endothelial and blood cells.
2. Materials and methods
2.1. Materials
Materials were obtained from the following sources. D-[2,6-3H]-
mannose (speci¢c radioactivity 2 TBq/mmol) was from Amersham
Buchler (Braunschweig, Germany). Dowex AG50W-X12 (hydrogen
form) and Dowex AG3-X4 (free base form) were from Bio-Rad
(Mu«nchen, Germany). Unless otherwise stated, all other chemicals
and reagents were either from Sigma (Deisenhofen, Germany) or
from Serva (Heidelberg, Germany). The oligosaccharides Man5ÿ9-
GlcNAc2 and 1-deoxymannojirimycin (dMM) were from Oxford Gly-
cosystems (Abingdon, UK).
2.2. Sample preparation
Venous blood was collected from healthy individuals and was al-
lowed to clot at 37‡C for 2 h. The serum was separated by centrifu-
gation at 3000Ug for 10 min.
2.3. Preparation of [3H]mannose-labelled oligosaccharides
HepG2 cells were metabolically labelled with [2,6-3H]mannose in
the presence of 1 mM dMM. Cells were then surface-labelled with
NHS-SS-biotin and biotinylated proteins were isolated from detergent
extracts by a⁄nity chromatography on streptavidin agarose [4]. Oli-
gosaccharides were released by PNGase F from heat-denatured and
trypsin-treated glycoproteins and were separated by HPAE chroma-
tography as described [4]. Fractions containing Man9GlcNAc2 or
Man8GlcNAc2, respectively, were pooled and passed through a col-
umn containing AG3-X4 in the bottom layer and AG50W-X12 in the
top layer. After washing with two bed volumes of water, the ¢ltrates
were dried by evaporation.
2.4. HPAE separation of oligosaccharides
Oligosaccharides were separated using a Dionex (Sunyvale, CA,
USA) DX-300 system and a CarboPac PA-100 (4U250 mm) in series
with a CarboPac PA-100 guard column as described [6]. Columns
were calibrated with authentic oligosaccharides Man5ÿ9GlcNAc2.
2.5. [3H]Man9GlcNAc2-mannosidase assay
[3H]Man9GlcNAc2-cleaving mannosidase activity was assayed in
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human serum by incubating 100 Wl of freshly prepared serum with
radiolabelled substrate (~1500 cpm) and 200 Wl of the reaction bu¡er:
sodium acetate (0.5 M, pH 4.0, 4.5, 5.0, 5.5) or sodium cacodylate (0.5
M, pH 6.0; 0.2 M, pH 6.5, 7.0, 7.5, 8.0) for 8 h at 37‡C. Immediately
after incubation, oligosaccharides and the released [3H]mannose were
puri¢ed by mixed bed ion exchange chromatography and analyzed by
HPAE chromatography. Inhibition studies were carried out by pre-
incubating the samples in the presence of 1 mM dMM, 1 mM swain-
sonine or 20 mM EDTA for 30 min at 37‡C. After preincubation, the
samples were assayed for [3H]Man9GlcNAc2-mannosidase activity at
pH 6.5 for 4 h at 37‡C in the presence of the inhibitor. To examine the
Ca2-dependence, 30 mM CaCl2 was added after the incubation with
EDTA.
3. Results and discussion
3.1. Identi¢cation of a soluble K-mannosidase in human serum
To identify soluble class I mannosidases in human serum,
freshly prepared serum samples were assayed for the
[3H]Man9GlcNAc2-cleaving activity. The substrate
[3H]Man9GlcNAc2 was prepared from HepG2 cells after met-
abolic labelling with [3H]mannose as described in section 2.
The mannosidase activity was assayed at various pH values
ranging from pH 4.0 to 8.0. Separation of the reaction prod-
ucts by HPAE chromatography clearly showed a mannosidase
activity cleaving Man9GlcNAc2 to Man5ÿ8GlcNAc2 and free
mannose in a pH-dependent manner (Fig. 1A). The soluble K-
mannosidase in serum showed an optimal activity at pH 6.0
where Man6GlcNAc2 was the major product. 30^64% of the
enzyme remained active at pH 7.0^7.5, whereas only a very
low activity was detected at pH 4.0^5.0 (Fig. 1B).
3.2. Kinetics of the soluble serum K-mannosidase
As a measure for the substrate speci¢city, the time course of
Man9GlcNAc2 hydrolysis and formation of the reaction prod-
ucts by serum K-mannosidase was determined quantitatively
at pH 6.5. In these experiments, oligomannosidic N-glycans
and released [3H]mannose were analyzed by HPAE chroma-
tography after di¡erent times of incubation (Fig. 2). Human
serum mannosidase readily cleaved three of the four K1,2-
Fig. 1. In£uence of the pH on the [3H]Man9GlcNAc2-mannosidase activity present in human serum. (A) Serum samples were assayed for
[3H]Man9GlcNAc2 activity at the indicated pH. After incubation, oligosaccharides and the released [3H]mannose were analyzed by HPAE chro-
matography. M, mannose; 9, Man9GlcNAc2 ; 8, Man8GlcNAc2 ; 7, Man7GlcNAc2 ; 6, Man6GlcNAc2 ; 5, Man5GlcNAc2. (B) pH optimum of
the soluble K-mannosidase present in human serum.
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mannosidic linkages in the substrate Man9GlcNAc2 to form
Man6GlcNAc2 but displayed only a marginal activity towards
the major product Man6GlcNAc2. The oligosaccharide Man6-
GlcNAc2 was also shown to accumulate as a reaction product
when class I mannosidases, Man9-mannosidase and Golgi-
mannosidases IA and IB were incubated with the substrate
Man9GlcNAc2 [7^10]. Therefore, it is likely that the serum
mannosidase detected in the present study is related to these
class I mannosidases.
Data from HPAE fractionations were quantitated by total-
ing the radioactivity in each peak and by correcting for the
number of mannose residues, assuming that the speci¢c activ-
ity in all mannose residues is the same. In Fig. 3A, the radio-
activity of each oligosaccharide species, expressed as percent-
age of the total oligosaccharides recovered, is plotted versus
the time of incubation. The K-mannosidase activity was quan-
titated by determining the radioactivity of the released
[3H]mannose, expressed as percentage of the total radioactiv-
ity recovered (Fig. 3B). With the assumption of ¢rst order
kinetics, the release of [3H]mannose followed the equation
Dt = Dt!rU(13e3kt) where Dt is the extent of [3H]mannose
at the time t = x. The constant k can be determined from this
equation as the negative slope of a plot of ln(Dt!r3Dt) over
the time (Fig. 3C). The half-time of the [3H]mannose release
(4.2 h) was calculated according to the equation t1=2 = ln2/k.
Using the data of the hydrolysis of [3H]Man9GlcNAc2 (Fig.
Fig. 2. HPLC fractionation of the oligosaccharides generated from Man9GlcNAc2 by the soluble serum K-mannosidase after various times of
incubation. M and 5-9 indicate where free mannose and standard Man5ÿ9GlcNAc2 oligosaccharides fractionate on HPLC.
Fig. 3. Kinetic analysis of [3H]Man9GlcNAc2 hydrolysis by the soluble K-mannosidase from human serum. (A) The rate of appearance of the
oligosaccharide species generated from [3H]Man9GlcNAc2 by the serum K-mannosidase. Chromatographic data from the experiment in Fig. 2
were quantitated by totaling the radioactivity in each peak and correcting for the number of mannose residues in that species. The amount of
each oligosaccharide species is expressed as percentage of the total oligosaccharides recovered and plotted versus the time. (U) Man9GlcNAc2 ;
(8) Man8GlcNAc2 ; (R) Man7GlcNAc2 ; (a) Man6GlcNAc2 ; (F) Man5GlcNAc2. (B) The percentage of [3H]mannose released at each time
point was determined from the radioactivity eluting in the position of free mannose on HPLC (see Fig. 2). (C) Plot of ln(Dt!r3Dt) from the
data displayed in B versus the time. A linear regression leads to k = 0.1659 h31 (R2 = 0.999). (D) Plot of ln(Dt3Dt!r) from the hydrolysis of
Man9GlcNAc2 (data displayed in A) versus the time. A linear regression leads to k = 0.3827 h31 (R2 = 0.998).
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3A), a half-time of 1.8 h could be calculated for this process
(Fig. 3D). The hydrolysis of Man9GlcNAc2 by the serum K-
mannosidase occurs distinctly faster as compared to the half-
life of the majority of serum glycoproteins (for review, [11]) as
well as of cell surface glycoproteins (for review, [12]), indicat-
ing that oligomannosidic N-glycans on these glycoproteins
(for review, [13]) could undergo postbiosynthetic demanno-
sylation by this enzyme.
3.3. Enzymatic properties of the serum K-mannosidase.
The [3H]Man9GlcNAc2-mannosidase activity present in hu-
man serum could be completely blocked by the class I man-
nosidase inhibitor dMM, but was insensitive to the class II
inhibitor swainsonine (Table 1). From these results, it can be
concluded that human serum Man9GlcNAc2-mannosidase is a
class I mannosidase. So far, serum mannosidases have been
detected solely by the use of the arti¢cial substrates 4-nitro-
phenyl-K-D-mannopyranoside or methyumbelliferyl-K-D-man-
nopyranoside [14,15]. Since only class II mannosidases are
active towards aryl mannosides, the serum mannosidases de-
scribed so far [14,15] have to be regarded as class II manno-
sidases. Hence, the present data provide the ¢rst evidence for
the existence of a soluble class I mannosidase in serum. More-
over, the data support the conclusion that human serum does
not contain dMM-resistant, swainsonine-sensitive class II
mannosidases capable of cleaving Man9GlcNAc2 under stand-
ard assay conditions.
The soluble K1,2-mannosidase present in human serum was
strongly inhibited by EDTA. The full enzyme activity was
recovered when the incubation mixtures were supplemented
with an excess of Ca2 ions (Table 1). These data provide
further evidence that the soluble mannosidase belongs to the
class I mannosidases that contain an EF-hand Ca2 binding
consensus sequence and require Ca2 for activity [3].
The soluble serum K1,2-mannosidase exhibits similar enzy-
matic properties as the Man9-mannosidase [7,8,16] and Golgi-
mannosidases IA and IB [9,10,17,18]. Studies are under way
to examine whether serum mannosidase represents a proteo-
lytically-cleaved form or a secreted splice variant of one of
these membrane bound enzymes or may re£ect a protein en-
coded by a gene, unknown so far.
The physiological role of serum class I mannosidase is un-
known. The enzyme could be involved in demannosylation of
serum glycoproteins or plasma membrane glycoproteins on
endothelial cells or blood cells. Alternatively, serum class I
mannosidase could exhibit lectin-like properties and could
play a role in the recognition and binding of glycoconjugates
containing oligomannosidic oligosaccharides as has been
shown for mouse sperm surface K-mannosidase presumably
involved in the sperm-egg binding [19].
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Table 1
Enzymatic properties of the K-mannosidase from human serum
E¡ectors Relative activity (%)
None 100
1 mM dMM 0.1
1 mM Swainsonin 108
20 mM EDTA 0.1
20 mM EDTA, 30 mM CaCl2 119
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